Intec Pharma Ltd. (NASDAQ:NTEC) and Global Cord Blood Corporation (NYSE:CO) compete with each other in the Biotechnology sector. We will analyze and contrast their dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation.
Table 1 highlights Intec Pharma Ltd. and Global Cord Blood Corporation’s top-line revenue, earnings per share and valuation.
Table 2 provides the net margins, return on assets and return on equity of the two firms.
Meanhile, Global Cord Blood Corporation’s yearly dividend is $0.08 per share and 1.1% dividend yield. Intec Pharma Ltd. does not pay a dividend.
Insider and Institutional Ownership
Intec Pharma Ltd. and Global Cord Blood Corporation has shares owned by institutional investors as follows: 39.64% and 17.4%. About 11.81% of Intec Pharma Ltd.’s share are owned by insiders. Insiders Competitively, owned 49.6% of Global Cord Blood Corporation